Literature DB >> 2752152

Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals.

G D Ehrlich1, J B Glaser, M A Abbott, D J Slamon, D Keith, M Sliwkowski, J Brandis, E Keitelman, Y Teramoto, L Papsidero.   

Abstract

The HTLV-I tax gene protein (Tax) is not packaged within the mature viral particle from which the proteins for the commercially available enzyme-linked immunosorbent assay (ELISA) are derived. Screening of 162 individuals within a cohort of white intravenous (IV) drug abusers, previously identified as having an increased incidence of HTLV-I infection, demonstrated that seven of them had antibodies to the HTLV-I Tax protein but tested negative in HTLV-I ELISAs and Western blots prepared from purified virion proteins. Three out of 35 individuals in other behaviorally defined high-risk groups also displayed this limited pattern of reactivity to HTLV-I proteins. The presence of the anti-HTLV-I p40/Tax antibodies was determined by radioimmunoprecipitation assay (RIPA), which also revealed low levels of anti-env reactivity. The specificity of the anti-p40 reactivity was confirmed on specific Tax ELISAs and Western blots prepared from recombinantly produced Tax. In vitro gene amplification by the polymerase chain reaction (PCR) was used to establish the presence of sequences homologous to HTLV-I proviral DNA in four/four of these HTLV-I ELISA negative, Tax ELISA/Tax western blot/RIPA positive individuals. These data suggest that the true incidence of HTLV-I infection within high-risk cohorts is greater than previously reported.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752152

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.

Authors:  L D Papsidero; R P Dittmer; L Vaickus; B J Poiesz
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors.

Authors:  B Hjelle; R Mills; C Goldsmith; S G Swenson; S Cyrus
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples by using a monoclonal antibody immunoassay.

Authors:  L Papsidero; F Swartzwelder; M Sheu; R Montagna; G Ehrlich; S Bhagavati; H Dosik; J Sninsky; B Poiesz
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins.

Authors:  S R Coates; A J Harris; D L Parkes; C M Smith; H L Liu; R W Akita; M M Ferrer; E K Sampson; J W Brandis; M X Sliwkowski
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 5.  Non-HIV retroviral associations with rheumatic disease.

Authors:  D Zucker-Franklin
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

6.  HTLV Tax gene expression in patients with lymphoproliferative disorders.

Authors:  E A Cardoso; N Miranda; P Gameiro; M J Frade; M Figueiredo; A Parreira
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

7.  Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides.

Authors:  D Zucker-Franklin; E E Coutavas; M G Rush; D C Zouzias
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Episodic occurrence of antibodies against the bovine leukemia virus Rex protein during the course of infection in sheep.

Authors:  M A Powers; D Grossman; L C Kidd; K Radke
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II.

Authors:  D K Dube; M P Sherman; N K Saksena; V Bryz-Gornia; J Mendelson; J Love; C B Arnold; T Spicer; S Dube; J B Glaser
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  First Description of Seronegative HTLV-1 Carriers in Argentina.

Authors:  Sandra Gallego; María C Frutos; Sebastián Blanco; Gonzalo Castro; Marcos Balangero; David Elías Panigo; Arnaldo Mangeaud; Carlos Remondegui; Anderson Santos Rocha; Gabriela Melo Franco; Marina Lobato Martins; Edel Figueiredo Barbosa-Stancioli; Silvia Nates
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.